Skip to main content
AEON Biopharma, Inc. logo

AEON Biopharma, Inc. — Investor Relations & Filings

Ticker · AEON ISIN · US00775E1029 US Manufacturing
Open in API
Filings indexed 317 across all filing types
Latest filing 2021-01-21 Regulatory Filings
Country US United States of America
Listing US AEON

About AEON Biopharma, Inc.

https://www.aeonbiopharma.com/

AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company focused exclusively on developing therapeutic applications for botulinum toxins. The company is advancing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA), for the treatment of debilitating nervous system-related and neuromuscular disorders. Its lead clinical programs are investigating ABP-450 for the prevention of chronic and episodic migraines and the treatment of cervical dystonia. By concentrating solely on therapeutic indications, AEON aims to unlock the full potential of neurotoxins to provide lasting relief for patients with significant unmet medical needs.

Recent filings

Filing Released Lang Actions
S-1
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC). It is a registration statement under the Securities Act of 1933 for Priveterra Acquisition Corp., a blank check company (SPAC). The text includes details about the offering, the company, its management, and the intended use of proceeds. It is not an annual report, earnings release, or any other financial report but a registration statement for an initial public offering or securities offering. According to the filing definitions, this type of document is best classified under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit into other specific categories like Annual Report or Capital/Financing Update. The document length is substantial and contains detailed information typical of an S-1 filing, confirming the classification.
2021-01-21 English
Regulatory Filings 2020
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC by Priveterra Acquisition Corp. It is a detailed registration statement under the Securities Act of 1933, used for initial public offerings or other securities offerings. The text includes detailed information about the company, its management, risk factors, use of proceeds, capitalization, and other disclosures typical of an S-1 filing. This is not an annual report, earnings release, or any other report type but a registration statement for securities offering. The S-1 registration statement is a regulatory filing used to register securities with the SEC and is not covered by any other more specific category in the provided list. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2020-12-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.